Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
José María Rico-Gomis,
Antonio Palazón-Bru,
Irene Triano-García,
Luis Fabián Mahecha-García,
Ana García-Monsalve,
Andrés Navarro-Ruiz,
Berta Villagordo-Peñalver,
Jessica Jiménez-Abril,
Alicia Martínez-Hortelano,
Vicente Francisco Gil-Guillén
Affiliations
José María Rico-Gomis
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Alicante, Spain
Antonio Palazón-Bru
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Alicante, Spain
Irene Triano-García
Pharmacy Service, General University Hospital of Elche, Elche, Alicante, Spain
Luis Fabián Mahecha-García
Department of Psychiatry, General University Hospital of Elche, Elche, Alicante, Spain
Ana García-Monsalve
Pharmacy Service, General University Hospital of Elche, Elche, Alicante, Spain
Andrés Navarro-Ruiz
Pharmacy Service, General University Hospital of Elche, Elche, Alicante, Spain
Berta Villagordo-Peñalver
Department of Psychiatry, General University Hospital of Elche, Elche, Alicante, Spain
Jessica Jiménez-Abril
Department of Psychiatry, General University Hospital of Elche, Elche, Alicante, Spain
Alicia Martínez-Hortelano
Department of Psychiatry, General University Hospital of Elche, Elche, Alicante, Spain
Vicente Francisco Gil-Guillén
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Alicante, Spain
Few studies have assessed the association between the rs1414334 C/G polymorphism in the HTR2C gene and the development of the metabolic syndrome in patients treated with atypical antipsychotics. To provide further evidence, a cross-sectional study was conducted in Spain between 2012 and 2013 in 166 patients with these characteristics. In these patients, the association between the polymorphism and the presence of the metabolic syndrome was determined by implementing binary logistic regression models adjusted for variables associated with the metabolic syndrome. We did not confirm previous claims that the C allele of the polymorphism was linked to the metabolic syndrome: the association was in the opposite direction and non-significant. This conclusion held after taking gender and lifestyle variables into account.